Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Gas chromatography-mass spectrometry (GC-MS) analysis of tricarboxylic acid (TCA) cycle intermediates is a powerful analytical technique for quantifying central carbon metabolism metabolites in biological, clinical, and pharmaceutical research. This article provides a comprehensive technical overview of TCA cycle intermediate analysis by GC-MS, covering sample types, target analytes, derivatization strategies, chromatographic conditions, quality control, and downstream applications. Whether you are studying mitochondrial dysfunction, cancer metabolism, or microbial fermentation, this guide explains how GC-MS delivers sensitive, reproducible, and interpretable quantification of Krebs cycle metabolites.

GC-MS Analysis of TCA Cycle Intermediates: Principles, Methods, and Applications

Technical Overview

The tricarboxylic acid (TCA) cycle, also known as the Krebs cycle or citric acid cycle, is the central hub of cellular energy metabolism. It oxidizes acetyl-CoA derived from carbohydrates, lipids, and amino acids to generate NADH and FADH2, which feed the mitochondrial electron transport chain, while simultaneously supplying biosynthetic precursors for amino acids, nucleotides, and heme. Quantitative measurement of TCA cycle intermediates therefore provides a direct window into mitochondrial function, metabolic reprogramming, and whole-organism energy homeostasis.

Gas chromatography coupled with mass spectrometry (GC-MS) is one of the most established and reliable platforms for analyzing TCA cycle intermediates. The technique combines high chromatographic resolution with structurally informative mass spectral detection and mature electron ionization (EI) spectral libraries. Because TCA cycle intermediates are small, highly polar organic acids with poor thermal volatility, they must first be converted into volatile derivatives, typically trimethylsilyl (TMS) or tert-butyldimethylsilyl (TBDMS) esters. With proper derivatization and isotope-dilution internal standardization, GC-MS achieves detection limits in the low nanomolar range with excellent linearity and reproducibility, making it a cornerstone method in targeted metabolomics and metabolic flux analysis.

Testing Samples

GC-MS analysis of TCA cycle intermediates is applicable to a wide range of biological matrices. Proper sample collection, rapid quenching of metabolism, and low-temperature handling are critical to preserve the in vivo metabolite profile, as TCA intermediates turnover within seconds.

Animal Tissue Samples

Liver, brain, heart, kidney, skeletal muscle, adipose tissue, and tumor tissue can all be analyzed. Tissues should be excised rapidly, rinsed briefly to remove blood contamination, snap-frozen in liquid nitrogen, and stored at -80 °C. Typically 50-200 mg of tissue is sufficient per analysis.

Biofluid Samples

Plasma, serum, urine, cerebrospinal fluid, and amniotic fluid are commonly tested. Blood samples should be processed quickly at 4 °C to prevent ex vivo metabolic drift. Urine samples generally require normalization to creatinine or osmolality. A typical volume of 50-200 µL is required.

Cell Culture Samples

Cultured mammalian cells, suspension cells, and isolated primary cells are suitable. Metabolism must be quenched rapidly by adding cold solvent directly to washed cell pellets. Results are typically normalized to cell number, total protein, or DNA content. Approximately 1-5 million cells per sample are recommended.

Plant and Microbial Samples

Plant leaves, roots, seeds, fruits, and callus tissue, as well as bacteria, yeast, and fermentation broth, can be analyzed. Plant samples are often quenched and extracted in cold methanol-water mixtures, while microbial cultures require rapid filtration or centrifugation followed by cold solvent quenching to minimize metabolite leakage.

Testing Items

The standard GC-MS panel covers the core intermediates of the TCA cycle together with closely related organic acids of central carbon metabolism:

  • Pyruvic acid (glycolysis-TCA junction metabolite)
  • Citric acid (citrate)
  • cis-Aconitic acid
  • Isocitric acid
  • Alpha-ketoglutaric acid (2-oxoglutaric acid)
  • Succinic acid (succinate)
  • Fumaric acid (fumarate)
  • Malic acid (malate)
  • Oxaloacetic acid (oxaloacetate)
  • Lactic acid (related glycolytic end product)
  • Related metabolites such as 2-hydroxyglutaric acid, glutamic acid, and aspartic acid (available as extended panels)

Note: Succinyl-CoA is not directly measurable by GC-MS because CoA thioesters are unstable during extraction and derivatization; succinate is quantified as the corresponding readout instead.

Testing Methods

Sample Preparation and Extraction

Quenched samples are extracted with cold methanol/water (typically 80:20, v/v) or a methanol-water-chloroform biphasic system to simultaneously recover polar metabolites and lipids. Isotope-labeled internal standards, such as succinic acid-d4, citric acid-d4, or uniformly 13C-labeled organic acid mixtures, are added at the beginning of extraction to correct for matrix effects and instrument variability. After centrifugation, the polar phase is collected and dried under nitrogen or lyophilized.

Derivatization Strategy

A two-step derivatization is employed. First, methoximation with methoxyamine hydrochloride in pyridine protects keto groups (essential for pyruvate, oxaloacetate, and alpha-ketoglutarate) and prevents enol tautomerization that would otherwise produce multiple peaks. Second, silylation with BSTFA containing 1% TMCS, MSTFA, or MTBSTFA converts carboxyl and hydroxyl groups into volatile TMS or TBDMS derivatives. TBDMS derivatives offer greater stability and characteristic fragment ions, while TMS derivatives provide higher sensitivity for certain analytes.

GC-MS Instrumental Conditions

Derivatized extracts are analyzed on a gas chromatograph equipped with a low-bleed capillary column such as DB-5MS or HP-5MS (30 m × 0.25 mm × 0.25 µm), with high-purity helium as carrier gas at a constant flow of approximately 1.0 mL/min. A typical oven program starts at 60-70 °C, ramps at 5-10 °C/min to 300-320 °C, and holds to elute all derivatives. Detection uses electron ionization at 70 eV, and quantification is performed in selected ion monitoring (SIM) mode using one quantitative and at least two qualitative ions per analyte, with retention time and ion ratio confirmation against authentic standards.

Method Validation and Data Processing

Each batch includes calibration curves, quality control pools, procedural blanks, and duplicate samples. Key validation parameters include:

  • Linearity: calibration curves typically spanning 0.01-100 µM with correlation coefficients above 0.99
  • Limit of detection (LOD) and limit of quantification (LOQ) determined at signal-to-noise ratios of 3 and 10, respectively
  • Recovery: typically 80-120% for spiked matrix samples
  • Precision: intra-day and inter-day relative standard deviations generally below 15%
  • Stability assessment of derivatized samples in the autosampler

Raw data are processed using vendor software or platforms such as MassHunter, Xcalibur, or AMDIS, followed by manual inspection of chromatographic integration. Final concentrations are calculated by internal-standard-corrected calibration and reported with normalization options including per gram tissue, per milliliter biofluid, per million cells, or per gram fresh/dry weight.

Applications

Quantitative TCA cycle profiling by GC-MS supports a broad spectrum of research and development activities:

Cancer Metabolism Research

Alterations in TCA cycle flux are hallmarks of tumor metabolism. GC-MS quantification reveals accumulation of oncometabolites such as succinate and fumarate in SDH- and FH-deficient tumors, as well as elevated 2-hydroxyglutarate in IDH-mutant gliomas and leukemias, supporting biomarker discovery and therapeutic mechanism studies.

Mitochondrial Function and Toxicology

Accumulation or depletion of specific intermediates indicates impairment of respiratory chain complexes, pyruvate dehydrogenase, or Krebs cycle enzymes. The method is widely used to evaluate drug-induced mitochondrial toxicity, mitochondrial disease models, and oxidative stress responses.

Metabolic Disease Studies

Altered TCA intermediate levels in plasma and urine provide insight into diabetes, obesity, non-alcoholic fatty liver disease, and inborn errors of metabolism, enabling early biomarker identification and longitudinal monitoring.

13C Metabolic Flux Analysis

When combined with stable isotope tracing (13C-glucose, 13C-glutamine, or 13C-acetate), GC-MS mass isotopomer analysis of TCA intermediates quantitatively maps carbon flux through oxidative and reductive carboxylation pathways in cells and animal models.

Plant Science and Microbial Engineering

In plants, TCA intermediate profiles respond to stress, drought, and nutrient status. In industrial microbiology, monitoring organic acid pools guides strain engineering and fermentation process optimization for organic acid and amino acid production.

FAQ

Why is derivatization necessary for TCA cycle intermediates?

TCA cycle intermediates are polar organic acids with carboxyl, hydroxyl, and keto groups, making them thermally labile and non-volatile in their native form. Silylation and methoximation convert them into stable, volatile derivatives compatible with gas chromatography, dramatically improving peak shape, sensitivity, and reproducibility.

How should samples be collected and shipped?

All samples should be snap-frozen in liquid nitrogen immediately after collection and stored at -80 °C. Ship samples on dry ice with temperature monitoring to avoid freeze-thaw cycles, which cause significant degradation of labile intermediates such as oxaloacetate and cis-aconitate.

What is the minimum sample amount required?

Typical minimums are 50 mg tissue, 50 µL biofluid, or 1 million cells. Smaller samples may be accommodated with micro-scale extraction, though sensitivity may be reduced for low-abundance analytes.

What sensitivity and accuracy can be expected?

With SIM-mode detection and isotope-dilution quantification, detection limits in the low nanomolar to sub-micromolar range are routinely achieved, with linear calibration over two to three orders of magnitude and precision typically better than 15% RSD.

How long does a typical project take?

A standard project including method validation, sample analysis, and data reporting is generally completed within 2-4 weeks, depending on sample number and complexity. Rush timelines can often be arranged for time-sensitive studies.

Can TCA intermediates be combined with other metabolite classes?

Yes. The GC-MS organic acid assay is frequently combined with amino acid analysis, acylcarnitine profiling, and LC-MS-based lipidomics to deliver an integrated picture of central carbon and energy metabolism from a single biological sample.